Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2

Andrew B. Sharabi, Sung Hyung Lee, Margaret A. Goodell, Xue F. Huang, Si Yi Chen

Research output: Contribution to journalArticle

Abstract

The self-renewal and multilineage differentiation of embryonic stem cells (ESC) is largely governed by transcription factors or repressors. Extensive efforts have focused on elucidating critical factors that control the differentiation of specific cell lineages, for instance, myeloid lineages in hematopoietic development. In this study, we found that Twist-2, a basic helix-loop-helix (bHLH) transcription factor, plays a critical role in inhibiting the differentiation of ESC. Murine ES cells, in which Twist-2 expression is silenced by lentivirally delivered shRNA, exhibit an enhanced formation of primary embryoid bodies (EB) and enhanced differentiation into mesodermally derived hematopoietic colonies. Furthermore, Twist-2 silenced (LV-siTwist-2) ESC display significantly increased generation of myeloid lineages (Gr-1+ and F4/80+ cells) during in vitro hematopoietic differentiation. Treatment with the Toll-like receptor (TLR) 4 ligand synergistically stimulates the generation of primary EB formation as well as of hematopoietic progenitors differentiated from LV-siTwist-2 ES cells. Thus, this study reveals the critical role of the transcriptional repressor Twist-2 in regulating the development of myeloid lineage in hematopoietic differentiation from ESC. This study also suggests a potential strategy for directional differentiation of ESC by inhibiting a transcriptional repressor.

Original languageEnglish (US)
Pages (from-to)523-533
Number of pages11
JournalCloning and Stem Cells
Volume11
Issue number4
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Embryonic Stem Cells
Embryoid Bodies
Basic Helix-Loop-Helix Transcription Factors
Toll-Like Receptor 4
Cell Lineage
Small Interfering RNA
Transcription Factors
Ligands

ASJC Scopus subject areas

  • Biotechnology
  • Developmental Biology

Cite this

Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2. / Sharabi, Andrew B.; Lee, Sung Hyung; Goodell, Margaret A.; Huang, Xue F.; Chen, Si Yi.

In: Cloning and Stem Cells, Vol. 11, No. 4, 01.12.2009, p. 523-533.

Research output: Contribution to journalArticle

Sharabi, Andrew B. ; Lee, Sung Hyung ; Goodell, Margaret A. ; Huang, Xue F. ; Chen, Si Yi. / Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2. In: Cloning and Stem Cells. 2009 ; Vol. 11, No. 4. pp. 523-533.
@article{f4013d6518df423bae67f59d03ae70e2,
title = "Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2",
abstract = "The self-renewal and multilineage differentiation of embryonic stem cells (ESC) is largely governed by transcription factors or repressors. Extensive efforts have focused on elucidating critical factors that control the differentiation of specific cell lineages, for instance, myeloid lineages in hematopoietic development. In this study, we found that Twist-2, a basic helix-loop-helix (bHLH) transcription factor, plays a critical role in inhibiting the differentiation of ESC. Murine ES cells, in which Twist-2 expression is silenced by lentivirally delivered shRNA, exhibit an enhanced formation of primary embryoid bodies (EB) and enhanced differentiation into mesodermally derived hematopoietic colonies. Furthermore, Twist-2 silenced (LV-siTwist-2) ESC display significantly increased generation of myeloid lineages (Gr-1+ and F4/80+ cells) during in vitro hematopoietic differentiation. Treatment with the Toll-like receptor (TLR) 4 ligand synergistically stimulates the generation of primary EB formation as well as of hematopoietic progenitors differentiated from LV-siTwist-2 ES cells. Thus, this study reveals the critical role of the transcriptional repressor Twist-2 in regulating the development of myeloid lineage in hematopoietic differentiation from ESC. This study also suggests a potential strategy for directional differentiation of ESC by inhibiting a transcriptional repressor.",
author = "Sharabi, {Andrew B.} and Lee, {Sung Hyung} and Goodell, {Margaret A.} and Huang, {Xue F.} and Chen, {Si Yi}",
year = "2009",
month = "12",
day = "1",
doi = "10.1089/clo.2009.0020",
language = "English (US)",
volume = "11",
pages = "523--533",
journal = "Cellular Reprogramming",
issn = "2152-4971",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2

AU - Sharabi, Andrew B.

AU - Lee, Sung Hyung

AU - Goodell, Margaret A.

AU - Huang, Xue F.

AU - Chen, Si Yi

PY - 2009/12/1

Y1 - 2009/12/1

N2 - The self-renewal and multilineage differentiation of embryonic stem cells (ESC) is largely governed by transcription factors or repressors. Extensive efforts have focused on elucidating critical factors that control the differentiation of specific cell lineages, for instance, myeloid lineages in hematopoietic development. In this study, we found that Twist-2, a basic helix-loop-helix (bHLH) transcription factor, plays a critical role in inhibiting the differentiation of ESC. Murine ES cells, in which Twist-2 expression is silenced by lentivirally delivered shRNA, exhibit an enhanced formation of primary embryoid bodies (EB) and enhanced differentiation into mesodermally derived hematopoietic colonies. Furthermore, Twist-2 silenced (LV-siTwist-2) ESC display significantly increased generation of myeloid lineages (Gr-1+ and F4/80+ cells) during in vitro hematopoietic differentiation. Treatment with the Toll-like receptor (TLR) 4 ligand synergistically stimulates the generation of primary EB formation as well as of hematopoietic progenitors differentiated from LV-siTwist-2 ES cells. Thus, this study reveals the critical role of the transcriptional repressor Twist-2 in regulating the development of myeloid lineage in hematopoietic differentiation from ESC. This study also suggests a potential strategy for directional differentiation of ESC by inhibiting a transcriptional repressor.

AB - The self-renewal and multilineage differentiation of embryonic stem cells (ESC) is largely governed by transcription factors or repressors. Extensive efforts have focused on elucidating critical factors that control the differentiation of specific cell lineages, for instance, myeloid lineages in hematopoietic development. In this study, we found that Twist-2, a basic helix-loop-helix (bHLH) transcription factor, plays a critical role in inhibiting the differentiation of ESC. Murine ES cells, in which Twist-2 expression is silenced by lentivirally delivered shRNA, exhibit an enhanced formation of primary embryoid bodies (EB) and enhanced differentiation into mesodermally derived hematopoietic colonies. Furthermore, Twist-2 silenced (LV-siTwist-2) ESC display significantly increased generation of myeloid lineages (Gr-1+ and F4/80+ cells) during in vitro hematopoietic differentiation. Treatment with the Toll-like receptor (TLR) 4 ligand synergistically stimulates the generation of primary EB formation as well as of hematopoietic progenitors differentiated from LV-siTwist-2 ES cells. Thus, this study reveals the critical role of the transcriptional repressor Twist-2 in regulating the development of myeloid lineage in hematopoietic differentiation from ESC. This study also suggests a potential strategy for directional differentiation of ESC by inhibiting a transcriptional repressor.

UR - http://www.scopus.com/inward/record.url?scp=73849130622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73849130622&partnerID=8YFLogxK

U2 - 10.1089/clo.2009.0020

DO - 10.1089/clo.2009.0020

M3 - Article

C2 - 20025523

AN - SCOPUS:73849130622

VL - 11

SP - 523

EP - 533

JO - Cellular Reprogramming

JF - Cellular Reprogramming

SN - 2152-4971

IS - 4

ER -